Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-575-3 | CAS number: 142-96-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
There are studies on skin and eye irritation of dibutyl ether available, which were performed according to standard guidelines and GLP.
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
Skin Irritation
Studies in Animals
In a GLP patch test according to EC guideline B.4. (1992) and OECD TG 404 (2002), dibutyl ether (purity > 99.3 %) was only slightly irritating to the skin of 3 male rabbits after a 4-hour semi-occlusive exposure. During the observation time a very slight erythema (barely perceptible, grade 1) was observed in all three rabbits 60 minutes and 24 hours after patch removal. In two animals the very slight erythema persisted until 72 hours after patch removal. A very slight edema (barely perceptible, grade 1) was observed in two animals 60 minutes after patch removal. All symptoms were reversible within 4 days after patch removal. The mean Draize scores of the 24, 48, and 72 hour readings for erythema were 1.0, 1.0, and 0.3 for the three test-animals, respectively, and for edema 0.0 for all three test-animals (Degussa AG, 2005a).
Eye Irritation
Studies in Animals
In a GLP study performed in accordance with EC guideline B.5. (1992) and OECD TG 405 (2002), the mean Draize scores of the 24, 48 and 72 hour readings after the instillation of 0.1 ml dibutyl ether (purity > 99.3 %) into the conjunctival sac were 0.0 regarding iris lesions, conjunctival redness, and conjunctival chemosis in all three male rabbits. Regarding corneal opacity the mean score was also 0.0 in two of the three test-animals and 0.3 in one rabbit. Opacity of grade 1 (scattered or diffuse areas of opacity (other than slight dulling of normal lustre), details of iris clearly visible) was observed in two animals 1 hour after instillation. In one of these two animals the slight opacity persisted until 24 hours after instillation. The fluorescein test performed 24 hours after instillation of the test item revealed corneal staining of one quarter of the surface in this animal. Irritation of the iris of grade 1 (markedly deepened rugae, congestion, swelling, moderate circumcorneal hyperemia, or injection, any of these or combination of any thereof, iris still reacting to light (sluggish reaction is positive)) was observed in one animal 1 hour after instillation. Conjunctival redness of grade 1 (some blood vessels definitely hyperemic (injected)) was observed in all three test-animals 1 hour after instillation. No changes, as compared to the untreated control eyes, were visible at 48-hours and 72-hours readings in any of the three test animals. The test substance produced no corrosion or irreversible effects in any of the animals (Degussa AG, 2005b).
Studies in Humans
In a study on sensory response to dibutyl ether, 200 ppm (corresponding to 1066 mg/m³) dibutyl ether were described as irritating to the eyes of a majority of 12 volunteers exposed in a gas cabinet to the substance for a period of 15 minutes (Silverman, Schulte and First, 1946). Based on the method described in another publication (Nelson et al., 1943) the authors didn’t differentiate between toxic and sensory effects (unpleasant, not necessarily toxic effects), therefore irritating doesn’t mean necessarily primary irritating effects.
Respiratory Tract Irritation
Studies in Animals
Rats exposed nose-only to 150, 500, or 1500 mg dibutyl ether/m³ 6 hours/day, 5 days/week for four weeks showed no clinical sign of respiratory tract irritation and no exposure-related histopathologic changes in the respiratory tract (for detailed study description see TNO, 2005).
Studies in Humans
In a study on sensory response to dibutyl ether, 200 ppm (corresponding to 1066 mg/m³) dibutyl ether were described as irritating to the eyes and nose, but not to the throat of a majority of 12 volunteers exposed in a gas cabinet to the substance for a period of 15 minutes (Silverman, Schulte and First, 1946). Based on the method described in another publication (Nelson et al., 1943) the authors didn’t differentiate between toxic and sensory effects (unpleasant, not necessarily toxic effects), therefore irritating doesn’t mean necessarily primary irritating effects.
Justification for classification or non-classification
Dibutyl ether is only very slightly irritating to the skin and the eyes of rabbits, as determined in GLP studies performed in accordance with OECD TG 404 and 405, respectively. All symptoms of irritation were completely reversible within 96 and 48 hours, respectively. In humans, a 15 minutes exposure towards 200 ppm (corresponding to 1066 mg/m³) dibutyl ether was reported to be sensory irritating to the eyes and the nose, but not to the throat. In a 28-day inhalation GLP study, performed according to standard guidelines, dibutyl ether at concentrations of up to and including 1500 mg/m³ was not irritating to the respiratory tract of rats. Therefore, the substance does not need to be classified and labelled for irritation, according to the Regulation 1271/2008 and the Directive 67/548/EEC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
